Carlo Giovanni Traverso, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Delivery Systems | 16 | 2019 | 2223 | 3.240 |
Why?
|
| Gastrointestinal Tract | 8 | 2018 | 831 | 2.250 |
Why?
|
| Wireless Technology | 2 | 2017 | 98 | 1.010 |
Why?
|
| Delayed-Action Preparations | 3 | 2018 | 962 | 0.960 |
Why?
|
| Stomach | 3 | 2016 | 694 | 0.860 |
Why?
|
| Swine | 14 | 2019 | 5915 | 0.860 |
Why?
|
| Administration, Oral | 6 | 2019 | 4013 | 0.760 |
Why?
|
| Antimalarials | 2 | 2018 | 907 | 0.710 |
Why?
|
| Colon | 4 | 2017 | 1792 | 0.690 |
Why?
|
| Gels | 2 | 2018 | 422 | 0.670 |
Why?
|
| Electronics | 2 | 2017 | 317 | 0.620 |
Why?
|
| Permeability | 2 | 2017 | 722 | 0.600 |
Why?
|
| Equipment Design | 3 | 2017 | 3510 | 0.600 |
Why?
|
| Malaria | 2 | 2018 | 1227 | 0.580 |
Why?
|
| Ivermectin | 1 | 2016 | 46 | 0.550 |
Why?
|
| Biological Products | 2 | 2017 | 913 | 0.550 |
Why?
|
| Macromolecular Substances | 1 | 2019 | 1435 | 0.530 |
Why?
|
| Anopheles | 1 | 2018 | 192 | 0.510 |
Why?
|
| Adhesives | 1 | 2016 | 65 | 0.510 |
Why?
|
| Elastomers | 1 | 2015 | 69 | 0.500 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 285 | 0.490 |
Why?
|
| Ultrasonics | 1 | 2015 | 207 | 0.470 |
Why?
|
| Respiratory Rate | 1 | 2015 | 176 | 0.470 |
Why?
|
| Gastric Mucosa | 1 | 2017 | 601 | 0.460 |
Why?
|
| Microinjections | 1 | 2014 | 321 | 0.450 |
Why?
|
| Biomedical Engineering | 1 | 2015 | 289 | 0.450 |
Why?
|
| Caffeine | 1 | 2018 | 700 | 0.440 |
Why?
|
| Mucous Membrane | 1 | 2016 | 657 | 0.410 |
Why?
|
| Monitoring, Ambulatory | 1 | 2015 | 354 | 0.410 |
Why?
|
| Pyridones | 1 | 2018 | 808 | 0.400 |
Why?
|
| Insulin | 2 | 2019 | 6595 | 0.400 |
Why?
|
| Foreign Medical Graduates | 1 | 2012 | 77 | 0.400 |
Why?
|
| Colitis | 3 | 2017 | 1231 | 0.390 |
Why?
|
| Biocompatible Materials | 2 | 2017 | 1689 | 0.390 |
Why?
|
| Hydrogels | 1 | 2017 | 721 | 0.390 |
Why?
|
| Polymers | 2 | 2016 | 1614 | 0.380 |
Why?
|
| Needles | 1 | 2014 | 451 | 0.380 |
Why?
|
| Anti-HIV Agents | 2 | 2018 | 4524 | 0.370 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 1088 | 0.320 |
Why?
|
| Feces | 4 | 2003 | 1495 | 0.320 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2016 | 1896 | 0.300 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3428 | 0.290 |
Why?
|
| Animals | 23 | 2019 | 168388 | 0.280 |
Why?
|
| Intestinal Absorption | 2 | 2019 | 400 | 0.280 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 1782 | 0.280 |
Why?
|
| Intestinal Mucosa | 3 | 2017 | 3027 | 0.270 |
Why?
|
| Chromosomal Instability | 2 | 2004 | 178 | 0.260 |
Why?
|
| Electric Power Supplies | 2 | 2017 | 97 | 0.250 |
Why?
|
| Esophagus | 3 | 2015 | 1030 | 0.240 |
Why?
|
| Colorectal Neoplasms | 8 | 2016 | 6901 | 0.230 |
Why?
|
| Heart Rate | 1 | 2015 | 4197 | 0.230 |
Why?
|
| Comet Assay | 1 | 2003 | 72 | 0.220 |
Why?
|
| Ultrasonography | 1 | 2017 | 5970 | 0.220 |
Why?
|
| DNA Mutational Analysis | 3 | 2016 | 4108 | 0.220 |
Why?
|
| Genes, APC | 2 | 2002 | 144 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2017 | 12787 | 0.200 |
Why?
|
| Spectrum Analysis | 1 | 2003 | 451 | 0.190 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 685 | 0.190 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 1968 | 0.190 |
Why?
|
| Water | 2 | 2018 | 1410 | 0.180 |
Why?
|
| Kinetics | 2 | 2018 | 6374 | 0.180 |
Why?
|
| Microsatellite Repeats | 2 | 2002 | 785 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 833 | 0.170 |
Why?
|
| Stainless Steel | 1 | 2019 | 79 | 0.160 |
Why?
|
| Algorithms | 3 | 2017 | 14025 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2003 | 1085 | 0.160 |
Why?
|
| Veterinary Medicine | 1 | 2018 | 21 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2003 | 851 | 0.150 |
Why?
|
| Cyanides | 1 | 2018 | 82 | 0.150 |
Why?
|
| Sus scrofa | 2 | 2017 | 428 | 0.150 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 1745 | 0.150 |
Why?
|
| Guanidines | 1 | 2018 | 192 | 0.150 |
Why?
|
| Hexuronic Acids | 1 | 2017 | 145 | 0.140 |
Why?
|
| Glucuronic Acid | 1 | 2017 | 150 | 0.140 |
Why?
|
| Compressive Strength | 1 | 2018 | 158 | 0.140 |
Why?
|
| Electronics, Medical | 1 | 2017 | 72 | 0.140 |
Why?
|
| Luciferases, Firefly | 1 | 2017 | 37 | 0.140 |
Why?
|
| Tensile Strength | 1 | 2018 | 330 | 0.140 |
Why?
|
| Acrylic Resins | 1 | 2017 | 135 | 0.140 |
Why?
|
| Polyesters | 1 | 2019 | 374 | 0.140 |
Why?
|
| Dosage Forms | 1 | 2016 | 56 | 0.140 |
Why?
|
| Miniaturization | 1 | 2017 | 153 | 0.140 |
Why?
|
| Contraceptive Devices, Female | 1 | 2016 | 40 | 0.140 |
Why?
|
| Capsules | 1 | 2016 | 191 | 0.130 |
Why?
|
| Culicidae | 1 | 2016 | 108 | 0.130 |
Why?
|
| Catalysis | 1 | 2018 | 774 | 0.130 |
Why?
|
| Primary Health Care | 1 | 2012 | 4685 | 0.130 |
Why?
|
| Alginates | 1 | 2017 | 248 | 0.130 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 255 | 0.130 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 944 | 0.130 |
Why?
|
| Dextrans | 1 | 2017 | 573 | 0.130 |
Why?
|
| Oxazines | 1 | 2018 | 349 | 0.130 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3577 | 0.120 |
Why?
|
| Technology, Pharmaceutical | 1 | 2015 | 84 | 0.120 |
Why?
|
| Tablets | 1 | 2015 | 147 | 0.120 |
Why?
|
| Endoscopy | 2 | 2016 | 1851 | 0.120 |
Why?
|
| Gastrointestinal Transit | 1 | 2015 | 99 | 0.120 |
Why?
|
| Physicians | 1 | 2012 | 4591 | 0.120 |
Why?
|
| Microspheres | 1 | 2017 | 785 | 0.120 |
Why?
|
| Finite Element Analysis | 1 | 2016 | 437 | 0.120 |
Why?
|
| Adenoma | 2 | 2002 | 2159 | 0.120 |
Why?
|
| Probiotics | 1 | 2018 | 377 | 0.120 |
Why?
|
| DNA | 3 | 2003 | 7216 | 0.110 |
Why?
|
| Biological Availability | 1 | 2014 | 390 | 0.110 |
Why?
|
| Burns, Chemical | 1 | 2014 | 122 | 0.110 |
Why?
|
| Humans | 32 | 2018 | 761326 | 0.110 |
Why?
|
| Materials Testing | 1 | 2017 | 864 | 0.110 |
Why?
|
| Photometry | 1 | 2013 | 58 | 0.110 |
Why?
|
| Mutation | 6 | 2018 | 30044 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1337 | 0.100 |
Why?
|
| Duodenum | 1 | 2015 | 489 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 5877 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.100 |
Why?
|
| Rabbits | 1 | 2018 | 4779 | 0.100 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 649 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 873 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2498 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1780 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2014 | 402 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 1198 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2015 | 712 | 0.080 |
Why?
|
| Cultural Diversity | 1 | 2012 | 368 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 22154 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2112 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.080 |
Why?
|
| Eating | 1 | 2014 | 1537 | 0.070 |
Why?
|
| Forecasting | 1 | 2016 | 2928 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2018 | 2690 | 0.070 |
Why?
|
| Piperazines | 1 | 2018 | 2519 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2012 | 702 | 0.070 |
Why?
|
| Patient Care | 1 | 2012 | 621 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8166 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.070 |
Why?
|
| Loss of Heterozygosity | 3 | 2003 | 662 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3611 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2821 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4355 | 0.060 |
Why?
|
| Female | 13 | 2018 | 392485 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15599 | 0.060 |
Why?
|
| RecQ Helicases | 1 | 2003 | 53 | 0.060 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2003 | 38 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12982 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1922 | 0.060 |
Why?
|
| Glioma | 1 | 2018 | 3455 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2015 | 2176 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2016 | 2279 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2003 | 402 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18962 | 0.050 |
Why?
|
| Rats | 1 | 2019 | 23729 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2003 | 182 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2002 | 181 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2002 | 5247 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2421 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4439 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 326 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20092 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4063 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2001 | 218 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1996 | 310 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1526 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2001 | 712 | 0.040 |
Why?
|
| Genes, ras | 1 | 2001 | 653 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 1996 | 4638 | 0.040 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2018 | 28 | 0.040 |
Why?
|
| Telemedicine | 1 | 2015 | 3041 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 2114 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2003 | 1509 | 0.040 |
Why?
|
| Holoprosencephaly | 1 | 1996 | 22 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9030 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 14665 | 0.030 |
Why?
|
| Heme | 1 | 2018 | 313 | 0.030 |
Why?
|
| Germ-Line Mutation | 2 | 2001 | 1858 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10760 | 0.030 |
Why?
|
| Rectum | 1 | 2000 | 892 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 6086 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1901 | 0.030 |
Why?
|
| Silver Compounds | 1 | 2014 | 23 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 69 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 142 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2014 | 405 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2002 | 1394 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 81474 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2625 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1996 | 1062 | 0.020 |
Why?
|
| Surface Properties | 1 | 2014 | 1160 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3666 | 0.020 |
Why?
|
| Pressure | 1 | 2014 | 1155 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2016 | 1218 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2001 | 2858 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 2804 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 1116 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3590 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 2644 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 17346 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 2534 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 1624 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3639 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4432 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2003 | 6571 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2015 | 1946 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2020 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6210 | 0.020 |
Why?
|
| Base Sequence | 3 | 2003 | 12449 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2013 | 2524 | 0.010 |
Why?
|
| United States | 1 | 2012 | 72317 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2000 | 9414 | 0.010 |
Why?
|
| Intestines | 1 | 2013 | 1909 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 22124 | 0.010 |
Why?
|
| Heterozygote | 2 | 2003 | 2803 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6768 | 0.010 |
Why?
|
| Emulsions | 1 | 2003 | 153 | 0.010 |
Why?
|
| Genetic Markers | 2 | 2001 | 2612 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6034 | 0.010 |
Why?
|
| Phenotype | 2 | 2016 | 16603 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2001 | 97 | 0.010 |
Why?
|
| Lod Score | 1 | 2001 | 602 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2001 | 277 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 2003 | 427 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 2000 | 81 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5768 | 0.010 |
Why?
|
| Magnetics | 1 | 2003 | 599 | 0.010 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2001 | 114 | 0.010 |
Why?
|
| Smad4 Protein | 1 | 2001 | 191 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 412 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1644 | 0.010 |
Why?
|
| Gene Deletion | 2 | 1996 | 2667 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1796 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1996 | 113 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 9468 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 1494 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 2820 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2014 | 42251 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 12666 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 17640 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2000 | 828 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 853 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1058 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9605 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2001 | 1114 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 2392 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2004 | 1711 | 0.010 |
Why?
|
| Cell Separation | 1 | 2000 | 1722 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17872 | 0.010 |
Why?
|
| Male | 3 | 2018 | 360621 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4466 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1344 | 0.010 |
Why?
|
| Middle Aged | 3 | 2002 | 220774 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5866 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6128 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 1996 | 570 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3448 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 36202 | 0.010 |
Why?
|
| Aged | 2 | 2002 | 169179 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1996 | 768 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1996 | 1125 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4175 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 1393 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1996 | 2509 | 0.010 |
Why?
|
| Adult | 2 | 2002 | 221122 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 21009 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 64645 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7582 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 11098 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 4286 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 13446 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11070 | 0.000 |
Why?
|
| Child | 2 | 2001 | 80156 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 8527 | 0.000 |
Why?
|
| Adolescent | 1 | 2001 | 88305 | 0.000 |
Why?
|
| Neoplasms | 1 | 2000 | 22158 | 0.000 |
Why?
|